Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
B-Temia has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Robotics Solution Companies - 2018,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Stephane Bedard, CEO.
Stephane Bedard, CEO
Bedard adds, “Having biomechanical knowledge of the human body plays a huge difference in understanding about how to artificially interact with the body, and we as a team are good at that. The in-depth knowledge of our team in biomechatronics enables us to understand the spectrum of the human mobility and develop a product accordingly.” B-Temia’s cross-functional team worked to design Keeogo™, a device that could aid individuals to overcome their physical limitations and enable more physical activity and endurance. With the product, the firm is creating a unique interface between humans and robotics, based in dermoskeletic principles that can improve the biomechanical functions of the human body and aid wearers in overcoming the limits of the human body for mobility. Bedard informs, “Albeit lately, the market has witnessed growth in human augmented systems with cutting-edge technologies; many products have not brought forth the desired results to individuals.” B-Temia entered the market to address the need for a human augmentation system that can address a broad spectrum of conditions and enable greater independence and freedom in mobility. Keeogo™ is used primarily to address orthopedic and neurological conditions and has benefited those with knee osteoarthritis, muscular or neuro-degenerative conditions, and those with spinal or brain injury. To create a more comprehensive picture of Keeogo™’s benefits, Bedard illustrates technical concepts behind the product. Firstly, he says, the Dermoskeleton™ uses advanced sensor networks and artificial intelligence for detecting an individuals’ intentions for movement in their environment and generates synchronized movements at the powered joints. Next, Keeogo™ detects the initiated movement of the body and aptly activates its motors to support completion of the movement. The ability to understand users’ intentions in real time is one of the key distinguishing features of this product. The other noteworthy aspect of Keeogo™ is that it can be configured as per the individual needs. For this, clients are evaluated to get a comprehensive picture of the characteristics and particularities of every user. The clinical support team and clinical partners of B-Temia are committed to providing a personalized experience to each user to make Keeogo™ the most preferred product of the market.![]()
Our aim is not only to commercialize Keeogo™ globally but to assist people in fulfilling the dream of climbing a mountain at 65
Mobility, Strength, and Autonomy for Everyone
Company
B-Temia
Management
Stephane Bedard, CEO
Description
A robotics technology company that develops and markets products for the growing market of human augmentation systems
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
